[{"Assets_0_Q2_USD":126409000.0,"EarningsPerShareBasic_1_Q2_USD":0.47,"EarningsPerShareBasic_2_Q2_USD":1.14,"EarningsPerShareDiluted_1_Q2_USD":0.44,"EarningsPerShareDiluted_2_Q2_USD":1.05,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":5425000.0,"NetIncomeLoss_1_Q2_USD":3333000.0,"NetIncomeLoss_2_Q2_USD":7940000.0,"StockholdersEquity_0_Q2_USD":96575000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":7632000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":7570000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":7069000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":6967000.0,"Ticker":"HSKA","CIK":"1038133","name":"HESKA CORP","OfficialName":"Heska Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1478587375.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170804"}]